Correlia Biosystems


Developer of a streamlined assay platform designed to reduce the time and cost for quantifying proteins for proteomic and pharmaceutical applications. The company’s platform provides multiplexing capabilities for large protein panels including cytokines and post-translational modifications with unparalleled speed and automation, enabling researchers to access large panel protein studies as well as reduces the cost and time to market for candidate drug compounds.

626 Bancroft Way
Suite A
Berkeley, CA 94710